NCT06188793NARecruiting

Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

University of Michigan

Start Date

2/13/2024

Completion Date

12/1/2026

Summary

The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting. The study hypothesizes that: * At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program * Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients with Inflammatory Bowel Disease and self-reported pain * Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine) Exclusion Criteria: * Patients that do not report pain * Anticipated length of hospital stay is less than 72 hours * Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition * Patients with binocular vision loss * Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease. * Patients that are currently pregnant

Interventions

DEVICE

Virtual reality-directed BGBT

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Inflammatory Bowel Diseases

Locations

University of Michigan

Ann Arbor, Michigan 48109

United States